These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 37249228)
1. Biotransformation and Gut Microbiota-Mediated Bioactivity of Flavonols. Wang M; Lu Y; Wu Q; Chen G; Zhao H; Ho CT; Li S J Agric Food Chem; 2023 Jun; 71(22):8317-8331. PubMed ID: 37249228 [TBL] [Abstract][Full Text] [Related]
2. Bioactivity of dietary polyphenols: The role of metabolites. Luca SV; Macovei I; Bujor A; Miron A; Skalicka-Woźniak K; Aprotosoaie AC; Trifan A Crit Rev Food Sci Nutr; 2020; 60(4):626-659. PubMed ID: 30614249 [TBL] [Abstract][Full Text] [Related]
3. Interactions between dietary flavonoids and the gut microbiome: a comprehensive review. Baky MH; Elshahed M; Wessjohann L; Farag MA Br J Nutr; 2022 Aug; 128(4):577-591. PubMed ID: 34511152 [TBL] [Abstract][Full Text] [Related]
5. The biological fate and bioefficacy of citrus flavonoids: bioavailability, biotransformation, and delivery systems. Zhang M; Zhu S; Yang W; Huang Q; Ho CT Food Funct; 2021 Apr; 12(8):3307-3323. PubMed ID: 33735339 [TBL] [Abstract][Full Text] [Related]
6. Gut microbiota in phytopharmacology: A comprehensive overview of concepts, reciprocal interactions, biotransformations and mode of actions. Dey P Pharmacol Res; 2019 Sep; 147():104367. PubMed ID: 31344423 [TBL] [Abstract][Full Text] [Related]
7. Role of Dietary Flavonoid Compounds in Driving Patterns of Microbial Community Assembly. Ivey KL; Chan AT; Izard J; Cassidy A; Rogers GB; Rimm EB mBio; 2019 Sep; 10(5):. PubMed ID: 31551328 [TBL] [Abstract][Full Text] [Related]
8. Influence of Intestinal Microbiota on the Catabolism of Flavonoids in Mice. Lin W; Wang W; Yang H; Wang D; Ling W J Food Sci; 2016 Dec; 81(12):H3026-H3034. PubMed ID: 27792839 [TBL] [Abstract][Full Text] [Related]
9. The role of metabolism (and the microbiome) in defining the clinical efficacy of dietary flavonoids. Cassidy A; Minihane AM Am J Clin Nutr; 2017 Jan; 105(1):10-22. PubMed ID: 27881391 [TBL] [Abstract][Full Text] [Related]
10. Review of Evidence and Perspectives of Flavonoids on Metabolic Syndrome and Neurodegenerative Disease. Zilli AMH; Zilli EM Protein Pept Lett; 2021; 28(7):725-734. PubMed ID: 33504293 [TBL] [Abstract][Full Text] [Related]
11. Whole Food-Based Approaches to Modulating Gut Microbiota and Associated Diseases. Han Y; Xiao H Annu Rev Food Sci Technol; 2020 Mar; 11():119-143. PubMed ID: 31951487 [TBL] [Abstract][Full Text] [Related]
12. Biotransformation of dietary phytoestrogens by gut microbes: A review on bidirectional interaction between phytoestrogen metabolism and gut microbiota. Seyed Hameed AS; Rawat PS; Meng X; Liu W Biotechnol Adv; 2020 Nov; 43():107576. PubMed ID: 32531317 [TBL] [Abstract][Full Text] [Related]
13. Antioxidant flavonols from fruits, vegetables and beverages: measurements and bioavailability. Crozier A; Burns J; Aziz AA; Stewart AJ; Rabiasz HS; Jenkins GI; Edwards CA; Lean ME Biol Res; 2000; 33(2):79-88. PubMed ID: 15693274 [TBL] [Abstract][Full Text] [Related]
14. Biotransformation of Liquiritigenin into Characteristic Metabolites by the Gut Microbiota. Keranmu A; Pan LB; Fu J; Han P; Yu H; Zhang ZW; Xu H; Yang XY; Hu JC; Zhang HJ; Bu MM; Jiang JD; Xing NZ; Wang Y Molecules; 2022 May; 27(10):. PubMed ID: 35630532 [TBL] [Abstract][Full Text] [Related]
15. Polyphenols: a route from bioavailability to bioactivity addressing potential health benefits to tackle human chronic diseases. Vivarelli S; Costa C; Teodoro M; Giambò F; Tsatsakis AM; Fenga C Arch Toxicol; 2023 Jan; 97(1):3-38. PubMed ID: 36260104 [TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota Modulation and Anti-Inflammatory Properties of Dietary Polyphenols in IBD: New and Consolidated Perspectives. Santino A; Scarano A; De Santis S; De Benedictis M; Giovinazzo G; Chieppa M Curr Pharm Des; 2017; 23(16):2344-2351. PubMed ID: 28176667 [TBL] [Abstract][Full Text] [Related]
17. A Comprehensive Review on Biotransformation, Interaction, and Health of Gut Microbiota and Bioactive Components. Zhang L; Ma XG Comb Chem High Throughput Screen; 2024; 27(11):1551-1565. PubMed ID: 37916626 [TBL] [Abstract][Full Text] [Related]
18. Bioavailability and health effects of dietary flavonols in man. Hollman PC; Katan MB Arch Toxicol Suppl; 1998; 20():237-48. PubMed ID: 9442297 [TBL] [Abstract][Full Text] [Related]
19. Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites. Monagas M; Urpi-Sarda M; Sánchez-Patán F; Llorach R; Garrido I; Gómez-Cordovés C; Andres-Lacueva C; Bartolomé B Food Funct; 2010 Dec; 1(3):233-53. PubMed ID: 21776473 [TBL] [Abstract][Full Text] [Related]
20. Flavonoid metabolism: the interaction of metabolites and gut microbiota. Murota K; Nakamura Y; Uehara M Biosci Biotechnol Biochem; 2018 Apr; 82(4):600-610. PubMed ID: 29504827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]